Nautilus Biotechnology (NAUT) Short Interest Ratio & Short Volume $2.61 +0.01 (+0.38%) (As of 11/1/2024 ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Nautilus Biotechnology Short Interest DataNautilus Biotechnology (NAUT) has a short interest of 1.21 million shares, representing 1.61% of the float (the number of shares available for trading by the public). This marks a 0.00% change in short interest from the previous month. The short interest ratio (days to cover) is 16.7, indicating that it would take 16.7 days of the average trading volume of 74,448 shares to cover all short positions.Current Short Interest1,210,000 sharesPrevious Short Interest1,210,000 sharesChange Vs. Previous MonthNo ChangeDollar Volume Sold Short$3.44 millionShort Interest Ratio16.7 Days to CoverLast Record DateOctober 15, 2024Outstanding Shares125,560,000 sharesFloat Size74,990,000 sharesShort Percent of Float1.61%Today's Trading Volume39,043 sharesAverage Trading Volume74,448 sharesToday's Volume Vs. Average52% Short Selling Nautilus Biotechnology? Sign up to receive the latest short interest report for Nautilus Biotechnology and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartNAUT Short Interest Over TimeNAUT Days to Cover Over TimeNAUT Percentage of Float Shorted Over Time Ad Paradigm PressEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… A predicted Trump would win. You won’t believe what he’s predicting now.Click here to see it because it’s a SHOCKER… Nautilus Biotechnology Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/15/20241,210,000 shares $3.44 million No Change1.6%16.7 $2.84 9/30/20241,210,000 shares $3.45 million -0.8%1.6%16.8 $2.85 9/15/20241,220,000 shares $3.54 million +3.4%1.6%15.8 $2.90 8/31/20241,180,000 shares $3.07 million -0.8%1.6%16.8 $2.60 8/15/20241,190,000 shares $2.75 million -0.8%1.6%16.1 $2.31 7/31/20241,200,000 shares $3.25 million +2.6%1.6%16.2 $2.71 Get the Latest News and Ratings for NAUT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Nautilus Biotechnology and its competitors with MarketBeat's FREE daily newsletter. 7/15/20241,170,000 shares $3.05 million -3.3%1.6%16.4 $2.61 6/30/20241,210,000 shares $2.83 million +5.2%1.6%17.3 $2.34 6/15/20241,150,000 shares $2.94 million +5.5%1.5%16.4 $2.56 5/31/20241,090,000 shares $2.99 million -0.9%1.5%14.8 $2.74 5/15/20241,100,000 shares $3.16 million -1.8%1.5%14.6 $2.87 4/30/20241,120,000 shares $2.84 million +0.9%2.0%14.5 $2.54 4/15/20241,110,000 shares $2.73 million -7.5%2.0%14.5 $2.46 3/31/20241,200,000 shares $3.53 million -2.4%2.1%15.4 $2.94 3/15/20241,230,000 shares $3.15 million -6.1%2.2%14.5 $2.56 2/29/20241,310,000 shares $3.52 million +6.5%2.1%14.5 $2.69 2/15/20241,230,000 shares $3.76 million No Change2.3%14.6 $3.06 1/31/20241,230,000 shares $3.42 million -0.8%2.3%13.7 $2.78 1/15/20241,240,000 shares $3.86 million -6.1%2.3%12.7 $3.11 12/31/20231,320,000 shares $3.95 million +1.5%2.5%12.7 $2.99 12/15/20231,300,000 shares $4.13 million +4.0%2.5%13.4 $3.18 11/30/20231,250,000 shares $3.44 million -8.8%2.4%14.1 $2.75 11/15/20231,370,000 shares $4.11 million +11.4%2.0%15.7 $3.00 10/31/20231,230,000 shares $3.15 million -6.1%2.3%15.3 $2.56 10/15/20231,310,000 shares $3.75 million -3.7%2.5%16.9 $2.86 9/30/20231,360,000 shares $4.30 million +5.4%2.0%18.8 $3.16 9/15/20231,290,000 shares $5.08 million -1.5%1.9%15 $3.94 8/31/20231,310,000 shares $4.23 million +8.3%1.9%12.2 $3.23 8/15/20231,210,000 shares $3.74 million +5.2%1.8%10.6 $3.09 7/31/20231,150,000 shares $3.78 million +11.7%1.7%9.9 $3.29 7/15/20231,030,000 shares $3.52 million +11.3%2.3%9.1 $3.42 6/30/2023925,100 shares $3.58 million +107.1%2.0%8.5 $3.87 6/15/2023446,800 shares $1.77 million -24.5%1.0%4.3 $3.97 5/31/2023591,700 shares $1.69 million +29.7%1.3%6 $2.86 5/15/2023456,200 shares $1.16 million +2.8%1.0%4.7 $2.55 4/30/2023443,800 shares $1.15 million +1.6%1.0%4.4 $2.58 4/15/2023436,900 shares $1.24 million -6.9%1.0%3.8 $2.83 3/31/2023469,300 shares $1.30 million -49.7%1.0%3.7 $2.77 3/15/2023932,300 shares $2.06 million +4.3%2.1%6.6 $2.21 2/28/2023894,200 shares $1.90 million -40.4%1.8%6.5 $2.12Watch this before it gets removed (Ad)If you missed it, my emergency election broadcast is now available - but will be removed soonClick here to watch it now. 2/15/20231,500,000 shares $3.09 million -0.7%3.0%10.9 $2.06 1/31/20231,510,000 shares $2.96 million -1.3%3.1%9.9 $1.96 1/15/20231,530,000 shares $3.15 million +0.7%3.1%9.7 $2.06 12/30/20221,520,000 shares $2.74 million -2.6%3.4%10.1 $1.80 12/15/20221,560,000 shares $2.45 million -2.5%3.5%10.4 $1.57 11/30/20221,600,000 shares $2.90 million -4.8%3.6%10.9 $1.81 11/15/20221,680,000 shares $3.38 million -8.7%3.8%11.3 $2.01 10/31/20221,840,000 shares $4.54 million -2.1%4.2%9.9 $2.47 10/15/20221,880,000 shares $3.84 million -2.1%4.3%9.5 $2.04 9/30/20221,920,000 shares $4.07 million -16.2%4.3%9.4 $2.12 9/15/20222,290,000 shares $5.06 million No Change5.2%7.5 $2.21 8/31/20222,290,000 shares $5.06 million +1.8%5.2%6.6 $2.21 8/15/20222,250,000 shares $6.35 million +0.5%5.1%6 $2.82 7/31/20222,240,000 shares $6.52 million -1.8%5.1%6.2 $2.91 7/15/20222,280,000 shares $6.22 million +3.6%5.2%6.1 $2.73 6/30/20222,200,000 shares $5.92 million +22.2%5.0%5.8 $2.69 6/15/20221,800,000 shares $4.86 million -17.1%4.1%4.8 $2.70 5/31/20222,170,000 shares $7.94 million +15.4%4.9%7.9 $3.66 5/15/20221,880,000 shares $7.03 million +6.2%4.3%7.2 $3.74 4/30/20221,770,000 shares $8.27 million +2.3%3.2%7 $4.67 4/15/20221,730,000 shares $7.01 million -3.4%3.1%6 $4.05 3/31/20221,790,000 shares $7.77 million +12.6%3.2%6 $4.34 3/15/20221,590,000 shares $5.84 million -4.8%2.8%4.4 $3.67 2/28/20221,670,000 shares $6.68 million +10.6%3.0%4.2 $4.00 2/15/20221,510,000 shares $6.10 million -9.0%3.2%3.5 $4.04 1/31/20221,660,000 shares $6.51 million -25.9%5.1%3.6 $3.92 1/15/20222,240,000 shares $9.92 million -54.8%6.7%5 $4.43 12/31/20214,950,000 shares $25.64 million +4.0%14.8%11 $5.18 12/15/20214,760,000 shares $25.09 million +7.0%14.3%10.8 $5.27 11/30/20214,450,000 shares $21.58 million -4.7%13.1%10.2 $4.85 11/15/20214,670,000 shares $25.03 million -6.6%13.7%10.8 $5.36 10/29/20215,000,000 shares $26.70 million +20.8%14.7%11.2 $5.34 10/15/20214,140,000 shares $23.64 million +6.2%12.1%4.7 $5.71 9/30/20213,900,000 shares $23.95 million +6.0%11.4%4.7 $6.14 9/15/20213,680,000 shares $26.16 million +3.1%10.8%4.5 $7.11 8/31/20213,570,000 shares $28.17 million +17.4%10.5%4.7 $7.89 8/13/20213,040,000 shares $23.23 million No Change8.9%4.3 $7.64 NAUT Short Interest - Frequently Asked Questions What is Nautilus Biotechnology's current short interest? Short interest is the volume of Nautilus Biotechnology shares that have been sold short but have not yet been closed out or covered. As of October 15th, investors have sold 1,210,000 shares of NAUT short. 1.61% of Nautilus Biotechnology's shares are currently sold short. Learn More on Nautilus Biotechnology's current short interest. What is a good short interest ratio for Nautilus Biotechnology? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. NAUT shares currently have a short interest ratio of 17.0. Learn More on Nautilus Biotechnology's short interest ratio. What is a good short interest percentage for Nautilus Biotechnology? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.61% of Nautilus Biotechnology's floating shares are currently sold short. What is Nautilus Biotechnology's float size? Nautilus Biotechnology currently has issued a total of 125,560,000 shares. Some of Nautilus Biotechnology's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Nautilus Biotechnology currently has a public float of 74,990,000 shares. How does Nautilus Biotechnology's short interest compare to its competitors? 1.61% of Nautilus Biotechnology's shares are currently sold short. Here is how the short interest of companies compare to Nautilus Biotechnology: Tenaya Therapeutics, Inc. (7.47%), ORIC Pharmaceuticals, Inc. (17.01%), BioAtla, Inc. (10.84%), Affimed (7.23%), Transcat, Inc. (3.18%), Standard BioTools Inc. (5.94%), Cytek Biosciences, Inc. (3.74%), EyePoint Pharmaceuticals, Inc. (17.13%), Quanterix Co. (6.92%), Aehr Test Systems (18.33%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.14 billion), AppLovin Co. ($3.15 billion), Paychex, Inc. ($2.69 billion), Nu Holdings Ltd. ($2.48 billion), Cencora, Inc. ($2.24 billion), International Paper ($2.04 billion), Tractor Supply ($1.96 billion), Coinbase Global, Inc. ($1.93 billion), Moderna, Inc. ($1.91 billion), and SoFi Technologies, Inc. ($1.84 billion). View all of the most shorted stocks. What does it mean to sell short Nautilus Biotechnology stock? Short selling NAUT is an investing strategy that aims to generate trading profit from Nautilus Biotechnology as its price is falling. NAUT shares are trading up $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Nautilus Biotechnology? A short squeeze for Nautilus Biotechnology occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of NAUT, which in turn drives the price of the stock up even further. How often is Nautilus Biotechnology's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NAUT, twice per month. The most recent reporting period available is October, 15 2024. More Short Interest Resources from MarketBeat Related Companies Tenaya Therapeutics Short Interest Data ORIC Pharmaceuticals Short Interest Data BioAtla Short Interest Data Affimed Short Interest Data Transcat Short Interest Data Standard BioTools Short Interest Data Cytek Biosciences Short Interest Data EyePoint Pharmaceuticals Short Interest Data Quanterix Short Interest Data Aehr Test Systems Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:NAUT) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredMusk Says ‘Dollar Will Be Worth Nothing…’Elon Musk just issued an urgent warning… It's no secret that Musk is able to move markets with his words…Crypto 101 Media | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredNvidia warning urgentI thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredNothing can stop this gold rallyAfter what's felt like nearly a decade of disappointing gains, gold is stronger than ever and continues to hit...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nautilus Biotechnology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nautilus Biotechnology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
